Neuro-Sys Overview
- Year Founded
-
2013
- Status
-
Private
- Employees
-
34
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
2
Neuro-Sys General Information
Description
Operator of a preclinical research and drug development firm intended to specialize in the pharmacology of neurodegenerative diseases. The company offers advanced in vitro and in vivo models of neurodegenerative diseases, mode of action research, and drug development, enabling clients to develop new treatments for neurodegenerative diseases.
Contact Information
Website
www.neuro-sys.comCorporate Office
- 410 Chemin Départemental 60
- 13120 Gardanne
- France
Corporate Office
- 410 Chemin Départemental 60
- 13120 Gardanne
- France
Neuro-Sys Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 2. Accelerator/Incubator | Completed | Generating Revenue | ||||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
Neuro-Sys Comparisons
Industry
Financing
Details
Neuro-Sys Competitors (79)
One of Neuro-Sys’s 79 competitors is Kainova Therapeutics, a Venture Capital-Backed company based in Montreal, Canada.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Kainova Therapeutics | Venture Capital-Backed | Montreal, Canada | ||||
| Innate Pharma | Formerly VC-backed | Marseille, France | ||||
| Inhibrx | Formerly VC-backed | La Jolla, CA | ||||
| Alnylam Pharmaceuticals | Formerly VC-backed | Cambridge, MA | ||||
| Molecular Partners | Formerly VC-backed | Zurich, Switzerland |
Neuro-Sys Signals
Neuro-Sys Investors (2)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| BigBooster | Accelerator/Incubator | |||
| Neptune Accelerator | Accelerator/Incubator |
Neuro-Sys Investments (1)
Neuro-Sys’s most recent deal was a Grant with Gain Therapeutics for . The deal was made on 23-Jul-2019.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Gain Therapeutics | 23-Jul-2019 | Grant | Drug Discovery |
Neuro-Sys FAQs
-
When was Neuro-Sys founded?
Neuro-Sys was founded in 2013.
-
Where is Neuro-Sys headquartered?
Neuro-Sys is headquartered in Gardanne, France.
-
What is the size of Neuro-Sys?
Neuro-Sys has 34 total employees.
-
What industry is Neuro-Sys in?
Neuro-Sys’s primary industry is Drug Discovery.
-
Is Neuro-Sys a private or public company?
Neuro-Sys is a Private company.
-
What is Neuro-Sys’s current revenue?
The current revenue for Neuro-Sys is .
-
Who are Neuro-Sys’s investors?
BigBooster and Neptune Accelerator have invested in Neuro-Sys.
-
Who are Neuro-Sys’s competitors?
Kainova Therapeutics, Innate Pharma, Inhibrx, Alnylam Pharmaceuticals, and Molecular Partners are some of the 79 competitors of Neuro-Sys.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process